Table 3 Comparison of intestinal involvement between IBDU, CD and UC groups at diagnosis and last follow-up [case n, (%)]
From: Clinical features of inflammatory bowel disease unclassified: a case-control study
| Â | IBDU (37) | UC (74) | p-value | CD (74) | p-value |
|---|---|---|---|---|---|
At diagnosis | Â | Â | |||
terminal ileum | 8(21.6%) | 7(9.5%) | 0.036 | 52(70.3%) | 0.000 |
ileocecum | 13(35.1%) | 19(25.7%) | 0.109 | 45(60.8%) | 0.043 |
ascending colon | 12(32.4%) | 30(40.5%) | 0.406 | 27(36.4%) | 0.887 |
transverse colon | 22(59.5%) | 37(50.0%) | 0.346 | 25(33.8%) | 0.010 |
descending colon | 22(59.5%) | 53(71.6%) | 0.197 | 23(31.1%) | 0.004 |
sigmoid colon | 24(64.9%) | 65(87.8%) | 0.004 | 22(29.7%) | 0.000 |
rectum | 15(40.5%) | 72(97.3%) | 0.000 | 11(14.9%) | 0.000 |
pancolitis | 8(21.6%) | 28(37.8%) | 0.085 | 9(12.1%) | 0.712 |
At last follow-up | Â | Â | |||
terminal ileum | 13(35.1%) | 7(9.5%) | 0.001 | 53(71.6%) | 0.000 |
ileocecum | 21(56.8%) | 27(36.5%) | 0.042 | 51(68.9%) | 0.206 |
ascending colon | 24(64.9%) | 40(54.1%) | 0.277 | 37(50.0%) | 0.138 |
transverse colon | 30(81.1%) | 58(78.4%) | 0.741 | 34(45.9%) | 0.000 |
descending colon | 28(75.7%) | 64(86.5%) | 0.154 | 31(41.9%) | 0.001 |
sigmoid colon | 30(81.1%) | 70(94.6%) | 0.050 | 25(33.8%) | 0.000 |
rectum | 22(59.4%) | 74(100.0%) | 0.000 | 12(16.2%) | 0.000 |
pancolitis | 22(59.4%) | 40(54.1%) | 0.833 | 15(20.2%) | 0.000 |
progression | 21(56.8%) | 26(35.1%) | 0.030 | 12(16.2%) | 0.000 |